Idt Australia Ltd, based in Australia, is a pharmaceutical company.
One of their notable products is ACETAZOLAMIDE USP, with a corresponding US DMF Number 12997.
Remarkably, this DMF maintains an Active status since its submission on May 21, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 19, 2013, and payment made on March 13, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II